It has been challenging to bring new features to the Apple Watch lineup, with the technology giant previously reported to have experienced a 19 percent shipments slump in Q4 2024 due to this very reason. Then again, it is a Herculean task to outfit a congested space with ‘state-of-the-art’ health sensors that will work accurately. For all the advancements that Apple has made in this space, blood glucose monitoring is one obstacle that the Cupertino firm has been unsuccessful in scaling. Fortunately, according to one analyst, those countless efforts will bear fruit two years from now, when the feature is expected to debut.
No evidence from the supply chain indicates that blood glucose monitoring will actually debut in the Apple Watch Series 13, hinting that the product roadmap could just be a hunch
A product timeline shared by GF Securities’ analyst Jeff Pu, which was shared by the tipster @Jukanlosreve on X and spotted by AppleInsider, mentions that blood glucose monitoring is just a couple of years away. The analyst also states that the more affordable Apple Vision Air and smart glasses will arrive in 2027, indicating that it will be quite a year for the trillion-dollar entity. However, back in 2023, we reported that the health-focused feature is still a long way from happening, with an estimation claiming that blood glucose monitoring could be around seven years away.
Bloomberg’s Mark Gurman stated that in 2023, the non-invasive feature reached a ‘proof of concept’ stage that resulted in a functional prototype. Unfortunately, the biggest reason for not adding it to an Apple Watch was that the sensor was too large, making it impractical to be outfitted in the wrist-mounted wearable. The latest Apple Watch Series 10 continues to ship with the older features the company introduced years ago, but we have reported on a prototype belonging to the same family that housed a mysterious sensor.
Apple Product Timeline by Jeff Pu, GF Securities Hong Kong pic.twitter.com/jEIGMi7Twv
— Jukan Choi (@Jukanlosreve) June 15, 2025
Unfortunately, the exact nature of this hardware could not be determined, and since there was no possible way for the software to interact with this prototype, we are stuck in limbo. Pu does not clarify in the product roadmap if any Apple Watch Ultra model will receive this blood glucose feature, nor is there any supply chain evidence confirming Apple’s plans. In short, these could just be the analyst’s personal predictions, which is why we should treat them with a pinch of salt and await more updates.
Follow Wccftech on Google to get more of our news coverage in your feeds.
